Dana dhuwit perusahaan: Qiagen NV (QGEN)

Tandha merek Qiagen N.V. (QGEN)

The potential of Qiagen N.V. (QGEN) relies on its dominance in laboratory equipment, as evidenced by changes in cash levels; 0.82 captures the current state of this parameter. The "printer-cartridge" model with closed reagents creates strong customer lock-in, while a flawless image as a global leader in genetics minimizes reputational risks, ensuring business stability within the DNA technology sector.

QGEN - Dhuwit awis lan setara dhuwit awis perusahaan Qiagen Group ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Qiagen N.V.

- indikator kapitalisasi bursa perusahaan:
Analisis wiwitan perusahaan:qiagen.com
Produk merek Qiagen

Steady demand for molecular research consumables provides Qiagen N.V. (QGEN) with a predictable inflow of liquidity. By analyzing the cash position chart, an investor can see the issuer's current financial reserve. Daily calculation of this metric allows for real-time tracking of the "safety cushion" without waiting for quarterly reports. Growth in this indicator confirms the business's high resilience to default, although excess cash may suggest an underutilization of capital.

Pesaing utama

Volume dana dhuwit perusahaan TEM|IONS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Repligen RGEN|RNA: Dhuwit awis lan setara dhuwit awis perusahaan|CRSP: Dhuwit awis perusahaan|GeneDx Corp (WGS) - Dhuwit awis perusahaan|RARE: Volume dana dhuwit perusahaan|BEAM - Aset likuid perusahaan|SRPT (Sarepta Therapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Twist Bioscience Inc (TWST)|Volume dana dhuwit perusahaan TXG|Aset likuid perusahaan Intellia|Stoke - Dhuwit awis perusahaan|BLFS: Dhuwit awis lan setara dhuwit awis perusahaan|Wave Life Sciences Corp - Volume dana dhuwit perusahaan|Maze Therapeutics, Inc. (MAZE) - Dhuwit awis perusahaan|Sionna Therapeutics Inc (SION) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Prime Medicine Corp|Dana dhuwit perusahaan tayshagtx.com|QURE - Posisi dhuwit perusahaan|Dhuwit awis perusahaan MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Posisi dhuwit perusahaan|Volume dana dhuwit perusahaan SLDB (Solid Biosciences Inc.)|Sisa dhuwit perusahaan OCGN|PacBio Corp - Volume dana dhuwit perusahaan|Benitec Biopharma Inc. (BNTC) - Dhuwit awis perusahaan|DSGN: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan RCKT|Dhuwit awis perusahaan FDMT|Dhuwit awis lan setara dhuwit awis perusahaan LXEO (Lexeo Therapeutics)|Volume dana dhuwit perusahaan KRRO|Editas Medicine, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Silence Therapeutics Inc. SLN|Volume dana dhuwit perusahaan ProQR Therapeutics N.V. PRQR|CDXS: Dhuwit awis perusahaan|Posisi dhuwit perusahaan Sangamo (SGMO)|NAUT (Nautilus Bio) - Dhuwit awis perusahaan|MGX - Aset likuid perusahaan|DTIL (Precision BioSciences Inc.) - Volume dana dhuwit perusahaan|generationbio.com (GBIO) - Aset likuid perusahaan|Dana dhuwit perusahaan Boundless Bio Inc (BOLD)|Volume dana dhuwit perusahaan Exicure Inc. (XCUR)|Dana dhuwit perusahaan imunon.com IMNN|Volume dana dhuwit perusahaan Phio Pharmaceuticals PHIO|Mustang Bio Inc - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan transcodetherapeutics.com|BNGO: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan APDN|BLUE (bluebirdbio.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan ImmunoPrecise Antibodies IPA|Dhuwit awis perusahaan OMGA (omegatherapeutics.com)|Volume dana dhuwit perusahaan Singular Genomics Systems, Inc. (OMIC)|Volume dana dhuwit perusahaan RGLS (Regulus Therapeutics, Inc.)|Volume dana dhuwit perusahaan Syros SYRS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan